The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BioAge Labs Inc shares valued at $47,376 were purchased by Barton Shane on Sep 27 ’24. At $18.00 per share, Barton Shane acquired 2,632 shares. The insider’s holdings grew to 2,632 shares worth approximately $10475.36 following the completion of this transaction.
Also, Pande Vijay Satyanand purchased 126,793 shares, netting a total of over 2,501,626 in proceeds. Following the buying of shares at $19.73 each, the insider now holds 1,026,793 shares.
Before that, Pande Vijay Satyanand had added 67,096 shares to its account. In a trade valued at $1,323,804, the Director bought BioAge Labs Inc shares for $19.73 each. Upon closing the transaction, the insider’s holdings increased to 67,096 shares, worth approximately $4.35 million.
As published in their initiating research note from William Blair on February 28, 2025, BioAge Labs Inc [BIOA] has been a Mkt perform. Analysts at Morgan Stanley downgraded the stock from ‘”an Overweight”‘ to ‘”an Underweight”‘ outlook in a report released in early December. As of December 09, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for BIOA. Earlier on December 09, 2024, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for BIOA stock which previously was a “a Buy”.
Analyzing BIOA Stock Performance
During the last five days, there has been a drop of approximately -3.16%. Over the course of the year, BioAge Labs Inc shares have dropped approximately -31.26%.
Support And Resistance Levels for BioAge Labs Inc (BIOA)
According to the 24-hour chart, there is a support level at 3.84, which, if violated, would cause prices to drop to 3.70. In the upper region, resistance lies at 4.07. The next price resistance is at 4.16. RSI (Relative Strength Index) is 49.23 on the 14-day chart, showing neutral technical sentiment.
